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Effects of hyperbaric oxygen on eye tracking abnormalities in males
after mild traumatic brain injury
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Abstract—The effects of hyperbaric oxygen (HBO2) on eye
movement abnormalities in 60 military servicemembers with at
least one mild traumatic brain injury (mTBI) from combat
were examined in a single-center, randomized, double-blind,
sham-controlled, prospective study at the Naval Medicine
Operational Training Center. During the 10 wk of the study,
each subject was delivered a series of 40, once a day, hyperbaric chamber compressions at a pressure of 2.0 atmospheres
absolute (ATA). At each session, subjects breathed one of three
preassigned oxygen fractions (10.5%, 75%, or 100%) for 1 h,
resulting in an oxygen exposure equivalent to breathing either
surface air, 100% oxygen at 1.5 ATA, or 100% oxygen at 2.0
ATA, respectively. Using a standardized, validated, computerized eye tracking protocol, fixation, saccades, and smooth pursuit eye movements were measured just prior to intervention
and immediately postintervention. Between- and within-groups
testing of pre- and postintervention means revealed no significant differences on eye movement abnormalities and no significant main effect for HBO2 at either 1.5 ATA or 2.0 ATA
equivalent compared with the sham-control. This study demonstrated that neither 1.5 nor 2.0 ATA equivalent HBO2 had an
effect on postconcussive eye movement abnormalities after
mTBI when compared with a sham-control.

INTRODUCTION
As a result of the significant numbers of Veterans and
servicemembers (SMs) who sustained mild traumatic
brain injuries (mTBI) from the Gulf wars, the U.S.
Department of Veterans Affairs (VA) and Department of
Defense (DoD) established integrated systems of care [1–
2]. Through 2011, nearly 1 in 10 Veterans who served in
Operation Enduring Freedom and Operation Iraqi Freedom and enrolled in the VA were diagnosed with at least
one deployment-related mTBI [3]. Of these individuals,

Abbreviations: ANOVA = analysis of variance, ATA = atmospheres absolute, DoD = Department of Defense, HBO2 =
hyperbaric oxygen, mTBI = mild traumatic brain injury,
NMOTC = Naval Medicine Operational Training Center,
PPCS = persistent postconcussive syndrome, RPQ = Rivermead Post-Concussion Questionnaire, SD = standard deviation, SM = servicemember, SPEM = smooth pursuit eye
movement, TBI = traumatic brain injury, VA = Department of
Veterans Affairs.
*
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Department of PM&R, Virginia Commonwealth University, 1223 East Marshall Street, Richmond, VA 23298; 804828-4231; fax: 804-828-6755. Email: lasile@aol.com
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more than 90 percent were also diagnosed with at least
one additional condition (e.g., posttraumatic stress disorder or pain) that likely complicated both the clinical presentation and subsequent treatment [3–4], a finding that
has been labeled Postdeployment Syndrome [5] and may
help explain the higher rate of persistent postconcussive
syndrome (PPCS) in military personnel than civilian
individuals [3]. Moreover, the high incidence of repeated
exposures to blast, with potential for cumulative brain
injury, may also contribute to prolongation of recovery
and difficulty in symptom attribution [6–7]. The persistence of often disabling symptoms in a high proportion of
returning SMs and Veterans has prompted the use of a
significant number of alternative treatment strategies,
including meditation, acupuncture, tai chi, continuum
movement therapy, and hyperbaric oxygen (HBO2) [3–8].
HBO2 has been advocated for the acute treatment of
carbon monoxide poisoning, burns, crush injuries, and air
embolism; the chronic management of pressure ulcers,
gangrene, radiation necrosis, brain abscess, anemia,
osteomyelitis, and retinal artery blockage; and to improve
the long-term effects of ischemic stroke, autism, and
cerebral palsy [9]. However, investigations evaluating the
effect of HBO2 on subjective measures of PPCS have not
demonstrated clinically meaningful improvement [8,10–
12]. In contrast to this lack of efficacy in subjective measures of brain dysfunction, there are many basic science
studies supporting the effects of HBO2 on objective findings of brain recovery in animals [13]. For example, in
brain-injured rodents, HBO2 promotes mitochondrial
recovery and decreases apoptosis in hypoxic nerve cells,
which is associated with cognitive recovery and a reduction in hippocampal neuronal cell loss [13–15]. The purported mechanisms of HBO2 on brain injury include
enhanced neural stem cell activation and growth, reduced
hypoxic-induced myelin damage, elevated cellular ATP
(adenosine triphosphate) levels, and upregulated HIF-1
(hypoxis-inducible factor-1) alpha-enhancing neuronal
tolerance to hypoxia [16–19]. Based on these positive
findings of HBO2 in animal models, we hypothesized
that objective measures of clinical brain function and
recovery would demonstrate improvements. To test this
hypothesis, we identified the central visual pathways as
an objective and readily accessible indicator of brain
health. Eye tracking, which measures the integrity of
these pathways, has been demonstrated as a user-friendly,
low-cost, noninvasive marker of individuals with mTBI
[20–24].

Common assessments of eye tracking include the
measurement of saccades, smooth pursuit eye movement
(SPEM), and fixation [23–24]. Saccades, the simultaneous movements of both eyes in the same direction allowing for fixation of the image on the fovea, are likely to be
affected by even mild brain injuries because they involve
the concerted interactions of multiple and diverse areas
of the brain [23]. Additionally, the various components of
saccades are largely free of cognitive influence and not
interdependent. SPEM has been examined in the traumatic brain injury (TBI) population and, although
believed to be a potential component of the difficult to
identify and diagnose visual complaints seen with mTBI,
research has produced equivocal results [24]. Data
involving fixation, defined as maintaining a foveal
image, in individuals with TBI have not been well studied, in part due to technical difficulties in measurement;
however, advances in both technology and data processing have overcome this.
Investigation of these movement parameters demonstrated differences between SPEM and saccades in individuals with PPCS and injury-free controls [20]. These
differences were noted in horizontal and vertical stepwise
target displacement task responses between individuals
with symptomatic mTBI and controls. Subjects with
symptomatic mTBI had smaller predicted peak velocities, longer durations, larger position errors, and smaller
saccadic amplitudes. These symptomatic subjects also
had amplitudes that were significantly larger for the horizontal smooth pursuit task, were more likely to respond
with smaller primary saccades to step changes in target
position, less accurately tracked the stepwise moving
targets, and had lower pursuit gain than controls [20].
No between-group differences were noted for fixation
measures.
For this investigation of the effects of HBO2 on
mTBI-related symptoms, we hypothesized that there
would be significant differences in postcompression
SPEM and saccadic eye movements between the sham
and intervention groups.

METHODS
This study was a sham-controlled, blinded, randomized,
three-arm trial of HBO2 exposure on combat-related,
symptomatic mTBI that was begun in 2009 at the Naval
Medicine Operational Training Center (NMOTC) at
Naval Air Station Pensacola. Other outcome measures
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from this trial have been reported [11–12]. This study
received appropriate governmental and institutional
review board approvals. Sixty-one Active Duty military
SMs with PPCS were recruited from U.S. military bases.
Inclusion criteria included confirmed diagnosis of mTBI
by a TBI specialist, postconcussive symptoms for at least
3 mo, injury occurrence within 3 yr, at least 2 mo stable
psychiatric status, and no change in psychotropic medications for at least 1 mo. The study physiatrist confirmed a
diagnosis of TBI based on history, physical examination,
and a review of all the medical records of the subjects,
including any available battlefield information, from the
time of the traumatic event to the present. Exclusion criteria included any contraindication to hyperbaric exposure, previous exposure to HBO2, or inability to undergo
testing (e.g., superimposed ophthalmic conditions such as
ocular injury and strabismus). All subjects were questioned as to whether they had any double vision, blurred
vision, or floaters. Demographics; clinical information;
and physical, cognitive, and measures of behavioral functioning were obtained.
After baseline testing, all subjects were relocated to
NMOTC for 2 mo to undergo the hyperbaric chamber
exposures. The hyperbaric chamber exposures, which
approximate the community standard of care and meet all
safety guidelines [8–9], have been described in prior publications from this research team [10–12].
Statistical Analyses
This article presents an analysis of the effects of the
hyperbaric chamber exposures on eye tracking characteristics of the control and treatment group members by
comparing baseline (time 1) measures to immediate postcompression (time 2), and 3 mo postcompression (time 3)
results. Immediate postcompression outcome measurements were obtained within the first week following last
exposure. Statistical measures of eye tracking were used
to test for changes within and between subject groups at
times 1, 2, and 3. Previous research has demonstrated the
utility of these measures in distinguishing between mTBI
and normal controls [20].
We analyzed multiple measures (see Figure) using a
mixed-model analysis of variance (ANOVA), with time
(times 1, 2, and 3) as the within-subjects factor and oxygen-level (groups A, B, and C) as the between-subjects
factor. The studentized residuals were analyzed for outliers and normality. If there was only one outlier, the analysis was done with and without it. In the cases of multiple
outliers or a large deviation from the assumption of nor-

Figure.
Measures for comparing saccadic and smooth pursuit data.

mality, we used nonparametric methods (Kruskal-Wallis
for between-group analysis and Friedman two-way
ANOVA by ranks for within-group). Levene’s test was
used to check homogeneity of variances and Box test was
used to check the assumptions of covariances. Sphericity
assumptions were also verified and, when violated, were
corrected using the Greenhouse-Geisser correction.
When the interaction term was significant, the
assumption of homogeneity of covariances was not met.
In these cases, we used nonparametric tests and performed separate repeated-measures ANOVAs for each
oxygen-level group, as well as separate one-way ANOVAs between oxygen-level groups at each time point.
Eye Tracking Procedures
The techniques used to obtain the pre- and posthyperbaric chamber exposure saccadic movement and SPEM
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have been described in prior publications from this
research team [20].

RESULTS
One-hundred twenty-eight subjects met the initial
study eligibility and consented for evaluation. Of the 128
candidates, 61 met the full study criteria and were randomly
assigned into one of the three groups. Primary reasons for
exclusion were active medication changes, schedule conflicts, and the inability to confirm the diagnosis of mTBI.
One of the 61 study participants was unavailable for the
immediate postintervention assessment. Less than 1 percent of all scheduled chamber sessions were postponed
because of medical complaints and all were rescheduled
per the protocol. All study subjects were male and had
sustained at least one mTBI, with the most recent TBI
occurring a mean of 8.5 mo (standard deviation [SD] =
6.58 mo, range = 3–39 mo) prior to the baseline assessments. The etiologies of mTBI included improvised
explosive device blast (85.3%), uncategorized blasts
(10.0%), rocket propelled grenades (3.0%), and mortar
attacks (1.7%). Self-reported additional concussions
(mean = 2.1, SD = 0.95, range = 1–4) prior to the most
recent blast injury were reported by just over 25 percent
of the subjects. Of the 60 subjects who completed all of
the pre- and postcompression procedures, 21 were in the
sham-control group, 18 were in the 1.5 atmospheres absolute (ATA) equivalent group, and 21 were in the 2.0 ATA
equivalent group. There was no precompression between
group differences on these variables, as previously
reported [11–12].
The 60-subject final sample had a mean age of 23.2 yr
(SD = 2.95). Forty-seven (78.3%) were Caucasian, 10
(16.7 %) were Hispanic, 2 (3.3%) were African American, and 1 (1.7%) was Native American. Of the 60 subjects, 19 were married, 38 were single, and 3 were
divorced. One-way ANOVA and chi-square analysis
revealed no between-group differences on demographics.
There were no clinician-recommended or self-reported
alterations of psychotropic medications by any subjects
during the study period.
The symptoms of the research cohort were characterized using the Rivermead Post-Concussion Questionnaire
(RPQ) [25], and these results, which demonstrated no
between-group differences before or after hyperbaric
chamber compressions, have been previously reported

[11]. Specific to this analysis, no subjects reported any
active difficulty with vision on the three vision-related
RPQ items—blurred vision, light sensitivity, and double
vision.
To determine if a treatment effect existed, analyses
were conducted for the eye tracking variables that had
been identified as abnormal in prior research [20]. These
variables were compared for between- and within-group
differences over the three time periods. At pretreatment,
there were no significant differences between groups for
eye movement variables, verifying the efficacy of randomization. At immediate and 3 mo postcompression, both
between- and within-group differences were examined.
Saccades
Saccadic data from each group were compared from
the horizontal and vertical target displacement tasks.
Data from horizontal and vertical direction eye movements were analyzed for the horizontal and vertical target
displacement tasks, respectively. For each subject, duration, peak velocity, saccadic amplitude, and peak acceleration for all saccades were fit to models for both
horizontal and vertical displacement tasks using the nonlinear curve fitting toolbox in MATLAB (MathWorks;
Natick, Massachusetts). For peak velocity and acceleration of saccades, exponential models were used, while for
saccadic duration a power function model was used [26].
After curves were fit for each subject, the predicted duration, peak velocity, and peak acceleration from the models for both the 1° and 5° saccades were compared
between and within groups. Other measures of saccadic
accuracy known to differ between mTBI and normal controls were also compared (Figure) [20]. Measures analyzed were mean (normalized and non-normalized) of the
absolute value and SD of the primary and final position
errors.
Horizontal Tracking
All of the fit data (peak velocity at amplitudes 1 and
5, peak acceleration at amplitudes 1 and 5, and duration
at amplitudes 1 and 5), the mean of the normalized primary position error, and the number of primary saccades
for the horizontal tracking tasks met the assumptions
needed for repeated measures ANOVA. For all measures,
there was no statistically significant interaction (α = 0.05
level) between the oxygen-condition and time. The main
effect of oxygen-level showed no statistically significant
differences between groups, and there were no significant
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within-group differences over time. When a potential statistical trend was identified (the p-value was between 0.05
and 0.10 for the interaction term), we performed separate
repeated measures ANOVAs for each oxygen-condition
and found no significant differences. p-Values and partial
eta-squared values are reported for each of the variables
that met the assumptions for the mixed model ANOVA in
the Table.
The mean of the normalized final position error, the
mean of the non-normalized primary position error, and
the SD of the normalized position error did not meet
assumptions and so univariate nonparametric tests were
performed. No significant differences between or within
groups were found.
Vertical Tracking
All of the data for the vertical tracking tasks met the
assumptions for parametric tests except for the mean and
SD of the normalized primary position errors. The data
for the mean of the normalized final error, predicted
velocity at 1° and 5°, predicted acceleration at 5°, and
predicted duration at 1° did not meet the assumption of
equal covariance, and therefore separate repeated measures ANOVAs were performed for each oxygen level.
Each variable that met the assumptions was analyzed
using a mixed-model ANOVA, with time (1, 2, and 3) as
the within-subjects factor and oxygen level (groups A, B,
and C) as the between-subjects factor. No significant
interactions between time and oxygen level were found.
The main effect of oxygen condition showed no statistically significant differences between groups, and there
were no significant within-group differences over time.

Of those variables for whom separate repeated measures ANOVAs for each group were calculated, no significant between-group differences on the factor of oxygen
level were found. Analyses of these measures within
groups found a statistically significant effect (or trend)
of time for two conditions: predicted velocity (51.25,
53.23, 49.30 °/s) and acceleration (2,982.98, 3,109.20,
2,835.02 °/s2) at both 1° and predicted velocity (209.21,
216.37, 203.19 °/s) and acceleration (11,294.69,
11,792.24, 10,934.80 °/s2) at 5° amplitudes for group B.
The difference was only statistically significant between
times 2 and 3 and reflected a slowing (or worsening) in
predicted values between times 2 and 3. The clinical relevance of slowing in these two parameters is unclear. No
other significant differences were found.
When nonparametric analyses were utilized, no significant between- or within-group results were found. pValues and partial eta-squared values are reported for
each of the variables that met the assumptions for the
mixed-model ANOVA in the Table.
Smooth Pursuit
Data for the horizontal and vertical smooth pursuit
eye movement tasks were analyzed. The minimum gain
and mean absolute normalized saccadic amplitude for
both pursuit tasks were analyzed. Only data for the minimum gain from the horizontal smooth pursuit task met
the assumptions for parametric tests. No significant interaction was found between the oxygen-condition factor
and time (p = 0.36, partial η2 = 0.047). The main effect of
oxygen condition also showed no statistically significant

Table.
Mixed-model analysis of variance results: tracking variables.

Tracking
Vertical
Mean of Non-Normalized Primary Position
Error
Number of Primary Saccades
Horizontal
Mean of Normalized Primary Position Error
Number of Primary Saccades
Predicted Velocity, 1° Amplitude
Predicted Velocity, 5° Amplitude
Predicted Acceleration, 1° Amplitude
Predicted Acceleration 5° Amplitude

Interaction, Oxygen Level (Between-Subjects) Main (Within-Subjects) Main
and Time
Effect, Oxygen Level
Effect, Time
2
2
p-Value
Partial Eta
p-Value
Partial Eta
p-Value
Partial Eta2
0.44

0.051

0.53

0.037

0.24

0.042

0.59

0.036

0.84

0.011

0.19

0.048

0.68
0.58
0.09
0.07
0.14
0.14

0.028
0.035
0.103
0.109
0.088
0.087

0.92
0.66
0.74
0.81
0.52
0.68

0.004
0.020
0.015
0.011
0.032
0.019

0.66
0.35
0.89
0.96
0.90
0.99

0.010
0.026
0.002
0.000
0.000
0.000
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Table.
Mixed-model analysis of variance results: tracking variables.

Predicted Duration, 1° Amplitude
Predicted Duration, 5° Amplitude

0.69
0.24

differences between groups (p = 0.10; η2 = 0.097), and
there were no significant within-group differences over
time (p = 0.85, η2 = 0.004). Nonparametric univariate
tests (within- and between-group) were performed on the
other three variables with no significant within- or
between-group differences found.

0.026
0.066

0.82
0.85

0.010
0.008

0.40
0.29

0.022
0.031

continued recovery for the next 3 mo [21,30–31]. Heitger
et al., in 2009, reported on 36 civilians who were within
6 mo of mTBI, and the mean RPQ score for light sensitivity was 1.42, 0.2 for double vision, and 0.78 for
blurred vision, all of which indicated that none of these
symptoms were more of a problem than prior to the
injury [31]. These findings are consistent with our findings of no meaningful visual complaints on the RPQ.

DISCUSSION
This investigation presents injury-related eye tracking characteristics from a subanalysis of a DoD-VA collaborative trial studying the effects of HBO2 on PPCS.
This represents the first examination utilizing objective
eye tracking measurements to assess the potential effect
of HBO2. In this study, there were no clinically significant between-group differences on any of the eye tracking
variables
following
hyperbaric
chamber
compressions. While there were within-group differences
on two of the saccade parameters for one of the oxygencondition groups, there were no clinical improvements
seen in any of the HBO2 conditions. Interestingly, the
changes seen between times 2 and 3 in this group B
reflected saccadic slowing rather than improvements in
eye functioning. The implications of this change are unclear
but certainly cannot be interpreted as beneficial. There
were no other statistically significant differences identified over the array of multiple eye movements studied.
The overall findings of this study were similar to
findings utilizing other outcome measures in this study
sample [11–12] and the initial DoD-VA study [10]. The
lack of differences among the three experimental conditions on these objective eye tracking measures suggests
the HBO2 exerted no treatment effects on the parameters
studied. These findings are noteworthy because this study
specifically utilized the typical treatment pressures advocated by hyperbaric clinicians [13,27–29].
Examinations of oculomotor abnormalities and
reports of visual dysfunction after mTBI, most commonly using the saccadic eye movements and the RPQ as
outcome measures, have demonstrated that they are most
likely seen in the first week after injury, maximally
recover in the initial 3 mo postinjury period and have

CONCLUSIONS
This study has a number of inherent limitations, as
previously described [11–12]. The small sample size limits the study’s power. Generalizability may be limited by
sex. Additionally, the high follow-up rate seen secondary
to the paid travel and Active Duty status (i.e., they
received additional duty orders to be on the base) may be
atypical of nonmilitary populations. A number of factors
common to most of the study participants may have an as
yet undetermined effect on eye movements, including
general combat exposure with associated posttraumatic
stress, depression, anxiety, substance abuse, and pain,
which all have been associated with deployment [3–4].
Future studies examining the effect of these comorbidities on eye tracking may be of interest. Better understanding of the influence of deployment and other possible
variables seen with the subjects, such as time postinjury,
severity of injury, repeated injury, and medication usage
and adjustments, may allow for a greater refinement of
treatment protocols. Diagnosing mTBI relies on participant self-report, which is sensitive to subjective patient
interpretation, memory, social desirability, and other
issues such as personality factors and willingness to
reveal problems; thus, subjects who report mTBI from
combat exposure may have characteristics that are not
typical of all individuals.
This well-controlled study of HBO2 use in symptomatic subjects with chronic mTBI demonstrated no significant eye movement improvements at either 1.5 or 2.0 ATA
equivalent over sham-control. Importantly, this investigation incorporated many features lacking in prior studies
of HBO2 use, including randomization, blinding, objec-
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tive outcome measure, and control groups. This investigation does not support a therapeutic role for HBO2 for
patients with persistent symptoms after mTBI. This
investigation utilized computerized eye tracking to examine the possible effects of hyperbaric exposures on individuals with mTBI with PPCS. There were no clinically
meaningful improvements associated with the exposure
to the HBO2.
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